Xue Wang

Also affiliated with University of Hawaii System, Cancer Center of Hawaii, First Affiliated Hospital of Zhengzhou University, University of Hawaii Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma”.

Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma

Cancer Research(2025)10.1158/0008-5472.can-25-1615

N/A

0.208DataRank · unranked

3 citations

Yi Zhou, Weiting Liao, Eleonora Cossu, Matthias Evert, Shu Zhang +19 more

Therapeutic Implementation of Oncolytic Viruses for Cancer Immunotherapy: Review of Challenges and Current Clinical Trials

Journal of biomedical science and research(2022)10.36266/jbsr/164

N/A

0DataRank · unranked

5 citations

Hoyoung Maeng, J Lee, Changqing Xie, Xue Wang

Targeting mTORC2-dependent AKT/FOXO1/RNF125 signaling exploits a therapeutic vulnerability in c-MET–activated and β-catenin–mutated hepatocellular carcinoma

Hepatology(2025)10.1097/hep.0000000000001637

N/A

0DataRank · unranked

2 citations

Yi Zhou, Shu Zhang, Christine Farrar, Xuemei Xie, Jian Li +18 more